References
NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994 Jul 6; 272(1): 65–9
Soll AD, on behalf of the Practice Parameters Committee of the American College of Gastroenterology. Medical treatment of peptic ulcer disease. Practice guidelines. JAMA 1996 Feb 28; 275(8): 622–9
Phull PS, Ryder SD, Halliday D, et al. The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease — a community-based study. Postgrad Med J 1995 Jul; 71: 413–8
Cottrill MRB. The prevalence of Helicobacter pylori infection in patients receiving long-term H2-receptor antagonists in general practice: clinical and financial consequences of eradication using omeprazole plus amoxycillin or triple therapy. Br J Med Econ 1994; 7: 35–41
Feldman M. The acid test. Making clinical sense of the consensus conference on Helicobacter pylori. JAMA 1994 Jul 6; 272(1): 70–1
Rauws EAJ, van der Hulst RWM. Current guidelines for the eradication of Helicobacter pylori in peptic ulcer disease. Drugs 1995; 50(6): 984–90
Penston JG. Review article: Helicobacter pylori eradication — understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369–89
Schwarz T. Helicobacter pylori research news. Inpharma 1995 Oct 14; (1008): 11–2
Rights and permissions
About this article
Cite this article
Guidelines for the eradication of Helicobacter pylori: why, who, and what?. Drugs Ther. Perspect 7, 7–10 (1996). https://doi.org/10.2165/00042310-199607080-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199607080-00003